Literature DB >> 6600169

Peripheral blood and intrathyroidal mononuclear cell populations in patients with autoimmune thyroid disorders enumerated using monoclonal antibodies.

J R Wall, R Baur, H Schleusener, P Bandy-Dafoe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6600169     DOI： 10.1210/jcem-56-1-164

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  21 in total

Review 1.  Immunotherapy through the IL-2 receptor.

Authors:  H A Verheul; M Verveld; E S Bos
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

2.  Surface expression and release of soluble forms of CD8 and CD23 in CD40- and IL-4-activated mononuclear cells from patients with Graves' disease (GD).

Authors:  M Itoh; K Uchimura; N Hayakawa; M Makino; R Hayashi; M Nagata; H Kakizawa; A Nagasaka; H Sakamoto; H Kuzuya
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

3.  Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.

Authors:  F A Karlsson; T H Tötterman
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

Review 4.  Delineating the autoimmune mechanisms in Graves' disease.

Authors:  Syed A Morshed; Rauf Latif; Terry F Davies
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

5.  Immunohistological phenotyping of thyroid infiltrating lymphocytes in Graves' disease and Hashimoto's thyroiditis.

Authors:  T Misaki; J Konishi; T Nakashima; Y Iida; K Kasagi; K Endo; T Uchiyama; K Kuma; K Torizuka
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

6.  Immunological features of sporadic multinodular goiter.

Authors:  J J Corrales; A Orfao; J M Miralles; M C López-Berges; L C García; M González; M T Mories; J San Miguel
Journal:  Clin Investig       Date:  1993-07

7.  Decrease of peripheral large granular lymphocytes in Graves' disease.

Authors:  Y Iwatani; N Amino; O Kabutomori; H Mori; H Tamaki; S Motoi; Y Izumiguchi; K Miyai
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

8.  Analysis of T cell subsets in Graves' disease: alterations associated with carbimazole.

Authors:  M E Ludgate; A M McGregor; A P Weetman; S Ratanachaiyavong; J H Lazarus; R Hall; G W Middleton
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-18

9.  Alterations in lymphocyte subpopulations in type 1 (insulin-dependent) diabetes mellitus: exploration of possible mechanisms and relationships to autoimmune phenomena.

Authors:  K C Herold; A Huen; L Gould; H Traisman; A H Rubenstein
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

10.  Effect of carbimazole treatment on specific and non-specific immunological parameters in patients with Graves' disease.

Authors:  J Charreire; G Karsenty; P Bouchard; G Schaison
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.